DK2518509T3 - Molekylær prognose og klassificering af malignt melanom på basis af markører fra listen RGS1, NCOA3, SPP1, PHIP - Google Patents
Molekylær prognose og klassificering af malignt melanom på basis af markører fra listen RGS1, NCOA3, SPP1, PHIPInfo
- Publication number
- DK2518509T3 DK2518509T3 DK12177684.3T DK12177684T DK2518509T3 DK 2518509 T3 DK2518509 T3 DK 2518509T3 DK 12177684 T DK12177684 T DK 12177684T DK 2518509 T3 DK2518509 T3 DK 2518509T3
- Authority
- DK
- Denmark
- Prior art keywords
- ncoa3
- rgs1
- phip
- spp1
- markers
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/136—Screening for pharmacological compounds
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/56—Staging of a disease; Further complications associated with the disease
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Organic Chemistry (AREA)
- Hospice & Palliative Care (AREA)
- General Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biophysics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US3410908P | 2008-03-05 | 2008-03-05 | |
EP09718437.8A EP2257810B1 (en) | 2008-03-05 | 2009-03-05 | Molecular diagnosis and classification of malignant melanoma |
Publications (1)
Publication Number | Publication Date |
---|---|
DK2518509T3 true DK2518509T3 (da) | 2014-08-18 |
Family
ID=41056372
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK09718437.8T DK2257810T3 (da) | 2008-03-05 | 2009-03-05 | Molekylær diagnose og klassificering af malignt melanom |
DK12177684.3T DK2518509T3 (da) | 2008-03-05 | 2009-03-05 | Molekylær prognose og klassificering af malignt melanom på basis af markører fra listen RGS1, NCOA3, SPP1, PHIP |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK09718437.8T DK2257810T3 (da) | 2008-03-05 | 2009-03-05 | Molekylær diagnose og klassificering af malignt melanom |
Country Status (10)
Country | Link |
---|---|
US (2) | US8492102B2 (da) |
EP (2) | EP2257810B1 (da) |
CN (1) | CN102037361A (da) |
AU (1) | AU2009221778A1 (da) |
CA (1) | CA2716357A1 (da) |
DK (2) | DK2257810T3 (da) |
ES (2) | ES2489840T3 (da) |
NZ (1) | NZ587750A (da) |
PT (2) | PT2257810E (da) |
WO (1) | WO2009111661A1 (da) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2009221778A1 (en) | 2008-03-05 | 2009-09-11 | The Regents Of The University Of California | Molecular diagnosis and classification of malignant melanoma |
CN102089444A (zh) | 2008-05-14 | 2011-06-08 | 德玛泰克国际公司 | 利用核酸分析方法来诊断黑素瘤和太阳能雀斑 |
CA2796942C (en) | 2010-04-20 | 2019-09-24 | Cornell University | Method for diagnosing melanocytic proliferations |
CN102998448A (zh) * | 2011-09-09 | 2013-03-27 | 上海市计划生育科学研究所 | 来源于前列腺分泌液中的前列腺癌标记物 |
US20160222457A1 (en) | 2012-11-14 | 2016-08-04 | Mayo Foundation For Medical Education And Research | Methods and materials for identifying malignant skin lesions |
AU2014241995B2 (en) | 2013-03-14 | 2020-01-16 | Castle Biosciences, Inc. | Methods for predicting risk of metastasis in cutaneous melanoma |
CA2906523A1 (en) | 2013-03-15 | 2014-09-25 | Myriad Genetics, Inc. | Genes and gene signatures for diagnosis and treatment of melanoma |
CN103472234B (zh) * | 2013-07-05 | 2015-01-07 | 武汉三鹰生物技术有限公司 | 一种酶联免疫检测及制备方法 |
CA2953016A1 (en) | 2014-07-02 | 2016-01-07 | Myriad Genetics, Inc. | Genes and gene signatures for diagnosis and treatment of melanoma |
US20170275700A1 (en) | 2014-08-14 | 2017-09-28 | Mayo Foundation For Medical Education And Research | Methods and materials for identifying metastatic malignant skin lesions and treating skin cancer |
WO2017196944A1 (en) | 2016-05-10 | 2017-11-16 | Mayo Foundation For Medical Education And Research | Methods and materials for staging and treating skin cancer |
AU2019222462A1 (en) | 2018-02-14 | 2020-09-03 | Dermtech, Inc. | Novel gene classifiers and uses thereof in non-melanoma skin cancers |
JP2022524641A (ja) | 2019-03-26 | 2022-05-09 | ダームテック,インク. | 皮膚癌における新規な遺伝子分類子とその使用 |
CN110438229A (zh) * | 2019-08-01 | 2019-11-12 | 上海交通大学 | 一种胃癌预后诊断生物标记物及其诊断试剂盒 |
CN113293214A (zh) * | 2021-06-17 | 2021-08-24 | 深圳华因康基因科技有限公司 | 一种检测神经母细胞瘤复发转移基因wnt2扩增的引物探针及其应用 |
CN115786504B (zh) * | 2022-08-31 | 2023-09-19 | 中国人民解放军总医院京南医疗区 | Hspa4抑制剂在治疗黑素瘤中的应用 |
Family Cites Families (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR6457315D0 (pt) | 1963-03-05 | 1973-08-09 | Yuki Kagaku Kogyo Kabush Tokyo | Composicao pesticida |
US3366308A (en) | 1966-04-11 | 1968-01-30 | Archer Products Inc | Collapsible container |
US4452720A (en) | 1980-06-04 | 1984-06-05 | Teijin Limited | Fluorescent composition having the ability to change wavelengths of light, shaped article of said composition as a light wavelength converting element and device for converting optical energy to electrical energy using said element |
US4439356A (en) | 1981-03-03 | 1984-03-27 | Syva Company | Unsymmetrical fluorescein derivatives |
US5506337A (en) | 1985-03-15 | 1996-04-09 | Antivirals Inc. | Morpholino-subunit combinatorial library and method |
US4987071A (en) | 1986-12-03 | 1991-01-22 | University Patents, Inc. | RNA ribozyme polymerases, dephosphorylases, restriction endoribonucleases and methods |
US5330900A (en) | 1987-12-31 | 1994-07-19 | Tropix, Inc. | Chemiluminescent 3-(substituted adamant-2'-ylidene) 1,2-dioxetanes |
US5010175A (en) | 1988-05-02 | 1991-04-23 | The Regents Of The University Of California | General method for producing and selecting peptides with specific properties |
US5066580A (en) | 1988-08-31 | 1991-11-19 | Becton Dickinson And Company | Xanthene dyes that emit to the red of fluorescein |
US5227487A (en) | 1990-04-16 | 1993-07-13 | Molecular Probes, Inc. | Certain tricyclic and pentacyclic-hetero nitrogen rhodol dyes |
IE66205B1 (en) | 1990-06-14 | 1995-12-13 | Paul A Bartlett | Polypeptide analogs |
US5650489A (en) | 1990-07-02 | 1997-07-22 | The Arizona Board Of Regents | Random bio-oligomer library, a method of synthesis thereof, and a method of use thereof |
US5750409A (en) | 1991-11-18 | 1998-05-12 | Boehringer Mannheim Gmbh | Pentacyclic compounds and their use as absorption or fluorescent dyes |
US5573905A (en) | 1992-03-30 | 1996-11-12 | The Scripps Research Institute | Encoded combinatorial chemical libraries |
US5885527A (en) | 1992-05-21 | 1999-03-23 | Biosite Diagnostics, Inc. | Diagnostic devices and apparatus for the controlled movement of reagents without membrances |
US5288514A (en) | 1992-09-14 | 1994-02-22 | The Regents Of The University Of California | Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support |
US5519134A (en) | 1994-01-11 | 1996-05-21 | Isis Pharmaceuticals, Inc. | Pyrrolidine-containing monomers and oligomers |
US5593853A (en) | 1994-02-09 | 1997-01-14 | Martek Corporation | Generation and screening of synthetic drug libraries |
US5539083A (en) | 1994-02-23 | 1996-07-23 | Isis Pharmaceuticals, Inc. | Peptide nucleic acid combinatorial libraries and improved methods of synthesis |
US6447796B1 (en) | 1994-05-16 | 2002-09-10 | The United States Of America As Represented By The Secretary Of The Army | Sustained release hydrophobic bioactive PLGA microspheres |
US5525735A (en) | 1994-06-22 | 1996-06-11 | Affymax Technologies Nv | Methods for synthesizing diverse collections of pyrrolidine compounds |
US5549974A (en) | 1994-06-23 | 1996-08-27 | Affymax Technologies Nv | Methods for the solid phase synthesis of thiazolidinones, metathiazanones, and derivatives thereof |
US5569588A (en) | 1995-08-09 | 1996-10-29 | The Regents Of The University Of California | Methods for drug screening |
US5847162A (en) | 1996-06-27 | 1998-12-08 | The Perkin Elmer Corporation | 4, 7-Dichlororhodamine dyes |
US6080852A (en) | 1996-06-27 | 2000-06-27 | The Perkin-Elmer Corporation | 4,7-dichlororhodamine dyes |
US6008379A (en) | 1997-10-01 | 1999-12-28 | The Perkin-Elmer Corporation | Aromatic-substituted xanthene dyes |
US5936087A (en) | 1997-11-25 | 1999-08-10 | The Perkin-Elmer Corporation | Dibenzorhodamine dyes |
MXPA01009073A (es) | 1999-03-10 | 2002-05-06 | Phogen Ltd | Suministro de acidos nucleicos y proteinas a las celulas. |
US20020155440A1 (en) * | 2000-12-19 | 2002-10-24 | Ljubimova Julia Y. | Using overexpression of laminin alpha 4 subunit as a diagnostic and prognostic indicator of malignant tumors |
US20020130430A1 (en) | 2000-12-29 | 2002-09-19 | Castor Trevor Percival | Methods for making polymer microspheres/nanospheres and encapsulating therapeutic proteins and other products |
US7247426B2 (en) * | 2001-08-02 | 2007-07-24 | Agilent Technologies, Inc. | Classifying cancers |
US7060498B1 (en) | 2001-11-28 | 2006-06-13 | Genta Salus Llc | Polycationic water soluble copolymer and method for transferring polyanionic macromolecules across biological barriers |
US7141540B2 (en) | 2001-11-30 | 2006-11-28 | Genta Salus Llc | Cyclodextrin grafted biocompatible amphilphilic polymer and methods of preparation and use thereof |
US20050222064A1 (en) | 2002-02-20 | 2005-10-06 | Sirna Therapeutics, Inc. | Polycationic compositions for cellular delivery of polynucleotides |
WO2004048545A2 (en) | 2002-11-26 | 2004-06-10 | University Of Massachusetts | DELIVERY OF siRNAs______________________________________________ |
EP1709195B1 (en) | 2003-12-19 | 2014-01-22 | Novartis Vaccines and Diagnostics, Inc. | Cell transfecting formulations of small interfering rna, related compositions and methods of making and use |
EP2145957B1 (en) | 2004-04-20 | 2013-12-25 | Marina Biotech, Inc. | Compositions for enhancing delivery of double-stranded RNA to regulate gene expression in mammalian cells |
US7514530B2 (en) | 2004-04-26 | 2009-04-07 | Centre National De La Recherche Scientifique | Peptide carrier for delivering siRNA into mammalian cells |
EP2062049B1 (en) * | 2006-09-06 | 2014-04-30 | The Regents of the University of California | Molecular diagnosis and classification of malignant melanoma |
US7615349B2 (en) * | 2006-09-07 | 2009-11-10 | H. Lee Moffitt Cancer Center And Research Institute, Inc. | Melanoma gene signature |
AU2009221778A1 (en) | 2008-03-05 | 2009-09-11 | The Regents Of The University Of California | Molecular diagnosis and classification of malignant melanoma |
-
2009
- 2009-03-05 AU AU2009221778A patent/AU2009221778A1/en not_active Abandoned
- 2009-03-05 DK DK09718437.8T patent/DK2257810T3/da active
- 2009-03-05 PT PT97184378T patent/PT2257810E/pt unknown
- 2009-03-05 PT PT121776843T patent/PT2518509E/pt unknown
- 2009-03-05 EP EP09718437.8A patent/EP2257810B1/en active Active
- 2009-03-05 CA CA2716357A patent/CA2716357A1/en not_active Abandoned
- 2009-03-05 ES ES12177684.3T patent/ES2489840T3/es active Active
- 2009-03-05 ES ES09718437T patent/ES2424329T3/es active Active
- 2009-03-05 NZ NZ587750A patent/NZ587750A/xx not_active IP Right Cessation
- 2009-03-05 EP EP12177684.3A patent/EP2518509B1/en active Active
- 2009-03-05 CN CN2009801161582A patent/CN102037361A/zh active Pending
- 2009-03-05 US US12/920,957 patent/US8492102B2/en active Active
- 2009-03-05 WO PCT/US2009/036227 patent/WO2009111661A1/en active Application Filing
- 2009-03-05 DK DK12177684.3T patent/DK2518509T3/da active
-
2013
- 2013-06-18 US US13/920,963 patent/US20130344481A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP2518509A2 (en) | 2012-10-31 |
PT2257810E (pt) | 2013-08-22 |
US20130344481A1 (en) | 2013-12-26 |
EP2518509B1 (en) | 2014-05-14 |
ES2489840T3 (es) | 2014-09-02 |
US8492102B2 (en) | 2013-07-23 |
CN102037361A (zh) | 2011-04-27 |
EP2257810A1 (en) | 2010-12-08 |
US20110123997A1 (en) | 2011-05-26 |
WO2009111661A1 (en) | 2009-09-11 |
EP2257810A4 (en) | 2011-06-08 |
AU2009221778A1 (en) | 2009-09-11 |
ES2424329T3 (es) | 2013-10-01 |
CA2716357A1 (en) | 2009-09-11 |
WO2009111661A9 (en) | 2010-06-10 |
NZ587750A (en) | 2012-10-26 |
EP2257810B1 (en) | 2013-06-05 |
EP2518509A3 (en) | 2013-01-23 |
DK2257810T3 (da) | 2013-07-15 |
PT2518509E (pt) | 2014-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2518509T3 (da) | Molekylær prognose og klassificering af malignt melanom på basis af markører fra listen RGS1, NCOA3, SPP1, PHIP | |
EP2108172A4 (en) | ADVERTISING RECOMMENDATION BASED ON SOCIAL RELATIONS | |
BRPI0907440A2 (pt) | estadiamento molecular de câncer de cólon em estágio ii e iii prognóstico | |
HK1132808A1 (en) | Contextual mobile local search based on social network vitality information | |
DE602008004610D1 (de) | Netzzustandserfassung und -reproduktion | |
BRPI1015948A2 (pt) | propagação de informação promocional em uma rede social. | |
NL2001666A1 (nl) | Multiple simultaneous frequency detection. | |
DE602008005376D1 (de) | Tragbares Informationsendgerät | |
BRPI0819811A2 (pt) | Identificação de setor usando assinaturas de parâmetros de setor | |
BRPI0917858A2 (pt) | conjunto de pás fixo de turbomáquina, e turbomáquina. | |
DK2600656T3 (da) | Systeminformationsopdateringer i LTE | |
DK2062049T3 (da) | Molekulær diagnose og klassificering af malignt melanoma | |
DK3176270T3 (da) | Forudsigelse af melanomcancerprognose | |
DK2257301T3 (da) | Immunterapi baseret på allogene cancerceller. | |
DK2197492T3 (da) | Hidtil ukendte præparater på basis af taxoider | |
FR2932482B1 (fr) | Nouveaux derives de (phenyl-3,6-dihydro-2h-pyridinyl)- (piperazinyl ponte)-1-alcanone et leur utilisation comme inhibiteurs de p75 | |
BRPI0807769A2 (pt) | Copolímero grafitizado. | |
FI20075484A (fi) | Tilaajan tunnistetietojen kuljettaminen | |
DK2306995T3 (da) | Antitumoregenskaber af umodificerede proteaseinhibitorer | |
DK2171083T3 (da) | Biosensing af molekylær konformation | |
ES1069126Y (es) | Soporte digital para publicidad o informacion | |
IT1401075B1 (it) | Pedonale di passaggio sopraelevata ad alta tecnologia | |
DK2367447T3 (da) | Havregrynsmorgenmadsprodukt fremstillet af små havregryn og fine dele | |
DE112009003295A5 (de) | Informationsübertragung für sich bewegende benutzer | |
FI7929U1 (fi) | Kelaatit ja leimausreagenssit |